Aurora Cannabis Inc. (TSE:ACB - Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as C$12.83 and last traded at C$12.65, with a volume of 7322643 shares trading hands. The stock had previously closed at C$8.65.
Wall Street Analyst Weigh In
Several equities research analysts recently commented on ACB shares. Jefferies Financial Group lowered their price target on Aurora Cannabis from C$6.12 to C$4.95 and set a "hold" rating for the company in a research note on Tuesday, February 27th. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a "hold" rating to a "buy" rating and set a C$0.80 price objective for the company in a research note on Friday, February 9th. Finally, CIBC lowered their target price on shares of Aurora Cannabis to C$6.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 21st.
Check Out Our Latest Stock Analysis on ACB
Aurora Cannabis Stock Performance
The stock has a fifty day moving average price of C$6.44 and a 200-day moving average price of C$2.67. The company has a current ratio of 3.79, a quick ratio of 2.48 and a debt-to-equity ratio of 18.51. The firm has a market capitalization of C$689.93 million, a price-to-earnings ratio of -0.16 and a beta of 2.83.
Aurora Cannabis (TSE:ACB - Get Free Report) last released its quarterly earnings data on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.10) by C($0.10). Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. The company had revenue of C$72.61 million for the quarter, compared to analyst estimates of C$63.50 million. As a group, analysts anticipate that Aurora Cannabis Inc. will post -0.22 earnings per share for the current fiscal year.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
